HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-DEC-16 5U6I TITLE DISCOVERY OF MLI-2, AN ORALLY AVAILABLE AND SELECTIVE LRRK2 INHIBITOR TITLE 2 THAT REDUCES BRAIN KINASE ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: MAPK1, ERK2, MAPK, PRKM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MLI-2, LRRK2, KINASE INHIBITOR, KINASE SELECTIVITY, PARKINSON'S KEYWDS 2 DISEASE, TRANSFERASE, SERINE/ THREONINE-PROTEIN KINASE, MAP KINASE, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.D.SCOTT,D.E.DEMONG,M.J.FELL,C.MIRESCU,K.BASU,T.J.GRESHOCK, AUTHOR 2 J.A.MORROW,L.XIAO,A.HRUZA,J.HARRIS,H.E.TISCIA,R.K.CHANG,M.W.EMBREY, AUTHOR 3 J.A.MCCAULEY,W.LI,S.LIN,H.LIU,X.DAI,M.BAPTISTA,G.AGNIHOTRI, AUTHOR 4 J.COLUMBUS,H.MEI,M.POIRIER,X.ZHOU,Y.LIN,Z.YIN,J.M.SANDERS, AUTHOR 5 R.E.DROLET,J.T.KERN,M.E.KENNEDY,E.M.PARKER,A.W.STAMFORD,R.NARGUND, AUTHOR 6 M.W.MILLER REVDAT 3 04-OCT-23 5U6I 1 REMARK REVDAT 2 26-APR-17 5U6I 1 JRNL REMARK REVDAT 1 15-MAR-17 5U6I 0 JRNL AUTH J.D.SCOTT,D.E.DEMONG,T.J.GRESHOCK,K.BASU,X.DAI,J.HARRIS, JRNL AUTH 2 A.HRUZA,S.W.LI,S.I.LIN,H.LIU,M.K.MACALA,Z.HU,H.MEI,H.ZHANG, JRNL AUTH 3 P.WALSH,M.POIRIER,Z.C.SHI,L.XIAO,G.AGNIHOTRI,M.A.BAPTISTA, JRNL AUTH 4 J.COLUMBUS,M.J.FELL,L.A.HYDE,R.KUVELKAR,Y.LIN,C.MIRESCU, JRNL AUTH 5 J.A.MORROW,Z.YIN,X.ZHANG,X.ZHOU,R.K.CHANG,M.W.EMBREY, JRNL AUTH 6 J.M.SANDERS,H.E.TISCIA,R.E.DROLET,J.T.KERN,S.M.SUR, JRNL AUTH 7 J.J.RENGER,M.T.BILODEAU,M.E.KENNEDY,E.M.PARKER,A.W.STAMFORD, JRNL AUTH 8 R.NARGUND,J.A.MCCAULEY,M.W.MILLER JRNL TITL DISCOVERY OF A 3-(4-PYRIMIDINYL) INDAZOLE (MLI-2), AN ORALLY JRNL TITL 2 AVAILABLE AND SELECTIVE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) JRNL TITL 3 INHIBITOR THAT REDUCES BRAIN KINASE ACTIVITY. JRNL REF J. MED. CHEM. V. 60 2983 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28245354 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00045 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 45301 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.186 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2270 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.73 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.27 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2944 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1860 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2813 REMARK 3 BIN R VALUE (WORKING SET) : 0.1830 REMARK 3 BIN FREE R VALUE : 0.2320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.45 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 131 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2768 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 252 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.88820 REMARK 3 B22 (A**2) : 1.05020 REMARK 3 B33 (A**2) : 0.83800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.190 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.090 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.084 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.107 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.082 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.957 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5699 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10305 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1260 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 74 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 840 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5699 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 368 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6345 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.49 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 52.3791 19.4135 19.2162 REMARK 3 T TENSOR REMARK 3 T11: -0.0533 T22: -0.0624 REMARK 3 T33: -0.0598 T12: -0.0006 REMARK 3 T13: -0.0045 T23: 0.0146 REMARK 3 L TENSOR REMARK 3 L11: 0.7812 L22: 0.8227 REMARK 3 L33: 0.9429 L12: -0.3067 REMARK 3 L13: -0.3906 L23: 0.1152 REMARK 3 S TENSOR REMARK 3 S11: 0.0063 S12: 0.0852 S13: -0.0518 REMARK 3 S21: -0.0633 S22: -0.0351 S23: 0.0857 REMARK 3 S31: -0.0114 S32: -0.0435 S33: 0.0288 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5U6I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1000225406. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION DECEMBER 6 2010 REMARK 200 DATA SCALING SOFTWARE : AUTOPROC, SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45409 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 17.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 0.62500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1ERK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES, PH 6.4, 2.0M AMMONIUM REMARK 280 SULFATE, 5% PEG 400, 0.5% DMSO, 1% GLYEROL, 0.0005M OLOMOUCINE, REMARK 280 18 DAY SOAK WITH NEW COMPOUND AT 500 MICROMOLAR CONCENTRATION, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.08900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.70800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.08900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.70800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -7 REMARK 465 ALA A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 PRO A 9 REMARK 465 GLU A 10 REMARK 465 MET A 11 REMARK 465 VAL A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 GLN A 15 REMARK 465 TYR A 34 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET A 291 SD MET A 291 CE -0.419 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 147 41.34 -148.03 REMARK 500 ASP A 165 80.64 68.74 REMARK 500 ASN A 199 13.92 -163.00 REMARK 500 ILE A 254 -63.94 71.84 REMARK 500 LEU A 292 44.37 -96.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 81Y A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 405 DBREF 5U6I A 1 358 UNP P63086 MK01_RAT 1 358 SEQADV 5U6I MET A -7 UNP P63086 INITIATING METHIONINE SEQADV 5U6I ALA A -6 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A -5 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A -4 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A -3 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A -2 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A -1 UNP P63086 EXPRESSION TAG SEQADV 5U6I HIS A 0 UNP P63086 EXPRESSION TAG SEQRES 1 A 366 MET ALA HIS HIS HIS HIS HIS HIS MET ALA ALA ALA ALA SEQRES 2 A 366 ALA ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE ASP SEQRES 3 A 366 VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY GLU SEQRES 4 A 366 GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN LEU SEQRES 5 A 366 ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO PHE SEQRES 6 A 366 GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU ILE SEQRES 7 A 366 LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE GLY SEQRES 8 A 366 ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN MET SEQRES 9 A 366 LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR ASP SEQRES 10 A 366 LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN ASP SEQRES 11 A 366 HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY LEU SEQRES 12 A 366 LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP LEU SEQRES 13 A 366 LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP LEU SEQRES 14 A 366 LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP PRO SEQRES 15 A 366 ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL ALA SEQRES 16 A 366 THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SER SEQRES 17 A 366 LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL GLY SEQRES 18 A 366 CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE PHE SEQRES 19 A 366 PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE LEU SEQRES 20 A 366 GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN CYS SEQRES 21 A 366 ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER LEU SEQRES 22 A 366 PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE PRO SEQRES 23 A 366 ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS MET SEQRES 24 A 366 LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU GLN SEQRES 25 A 366 ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP PRO SEQRES 26 A 366 SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE ASP SEQRES 27 A 366 MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS GLU SEQRES 28 A 366 LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY TYR SEQRES 29 A 366 ARG SER HET 81Y A 401 47 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HETNAM 81Y 3-[2-(MORPHOLIN-4-YL)PYRIDIN-4-YL]-5-[(PROPAN-2-YL) HETNAM 2 81Y OXY]-1H-INDAZOLE HETNAM SO4 SULFATE ION HETSYN 81Y MLI-2 FORMUL 2 81Y C19 H22 N4 O2 FORMUL 3 SO4 4(O4 S 2-) FORMUL 7 HOH *252(H2 O) HELIX 1 AA1 HIS A 59 PHE A 76 1 18 HELIX 2 AA2 LEU A 110 GLN A 117 1 8 HELIX 3 AA3 SER A 120 ALA A 141 1 22 HELIX 4 AA4 LYS A 149 SER A 151 5 3 HELIX 5 AA5 ASP A 173 ASP A 177 5 5 HELIX 6 AA6 THR A 188 ARG A 192 5 5 HELIX 7 AA7 ALA A 193 ASN A 199 1 7 HELIX 8 AA8 LYS A 205 ASN A 222 1 18 HELIX 9 AA9 HIS A 230 GLY A 243 1 14 HELIX 10 AB1 SER A 246 CYS A 252 1 7 HELIX 11 AB2 ASN A 255 LEU A 265 1 11 HELIX 12 AB3 PRO A 272 PHE A 277 1 6 HELIX 13 AB4 ASP A 281 LEU A 292 1 12 HELIX 14 AB5 GLU A 301 ALA A 307 1 7 HELIX 15 AB6 HIS A 308 GLU A 312 5 5 HELIX 16 AB7 ASP A 316 GLU A 320 5 5 HELIX 17 AB8 PRO A 337 ALA A 350 1 14 HELIX 18 AB9 ARG A 351 GLN A 353 5 3 SHEET 1 AA1 5 TYR A 23 GLU A 31 0 SHEET 2 AA1 5 MET A 36 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 AA1 5 VAL A 47 ILE A 54 -1 O VAL A 47 N ASP A 42 SHEET 4 AA1 5 VAL A 99 ASP A 104 -1 O VAL A 99 N ILE A 54 SHEET 5 AA1 5 ASP A 86 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 AA2 3 THR A 108 ASP A 109 0 SHEET 2 AA2 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 AA2 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AA3 2 VAL A 143 LEU A 144 0 SHEET 2 AA3 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 CISPEP 1 GLY A 20 PRO A 21 0 3.52 SITE 1 AC1 11 ALA A 50 GLN A 103 ASP A 104 LEU A 105 SITE 2 AC1 11 MET A 106 GLU A 107 THR A 108 LYS A 112 SITE 3 AC1 11 ASN A 152 LEU A 154 HOH A 635 SITE 1 AC2 7 ARG A 68 ARG A 170 VAL A 171 ASP A 330 SITE 2 AC2 7 MET A 331 HOH A 573 HOH A 596 SITE 1 AC3 7 ARG A 65 ARG A 146 ARG A 170 VAL A 186 SITE 2 AC3 7 TYR A 203 HOH A 502 HOH A 603 SITE 1 AC4 7 TYR A 185 ARG A 189 ARG A 192 TYR A 231 SITE 2 AC4 7 HOH A 569 HOH A 636 HOH A 658 SITE 1 AC5 8 ASP A 122 GLY A 180 LYS A 257 HOH A 530 SITE 2 AC5 8 HOH A 575 HOH A 638 HOH A 646 HOH A 665 CRYST1 70.178 91.416 62.541 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014249 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010939 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015990 0.00000